huahaipharm(SH:600521) Xin Lang Cai Jing·2025-09-23 05:29Group 1 - The core viewpoint of the news is that Huahai Pharmaceutical's stock has experienced a decline of 5.08% over three consecutive days, with the current stock price at 21.28 CNY per share and a total market capitalization of 31.862 billion CNY [1] - Huahai Pharmaceutical, established on February 28, 2001, and listed on March 4, 2003, specializes in the research, production, and sales of various types of generic drugs, biological drugs, innovative drugs, and specialty raw materials [1] - The company's main business revenue composition includes finished drug sales at 61.86%, raw materials and intermediates sales at 36.75%, other sales at 0.78%, and technical services at 0.62% [1] Group 2 - From the perspective of fund holdings, Jin Yuan Shun An Fund has a significant position in Huahai Pharmaceutical, with its Jin Yuan Shun An Medical Health Mixed A Fund (007861) holding 86,200 shares, accounting for 3.07% of the fund's net value [2] - The fund has incurred a floating loss of approximately 98,300 CNY today, with a total floating loss of 103,400 CNY during the three-day decline [2] - The Jin Yuan Shun An Medical Health Mixed A Fund was established on July 29, 2021, with a current scale of 33.4541 million CNY and has achieved a year-to-date return of 23.6% [2]